Liminal BioSciences Inc. LMNL

Set alert

Price alert · LMNL

All alert types
8.50 0.00 0.00%

As of Sep 25, 3:59 PM ET

8.48 Day range 8.50

52-week range unavailable

Open
8.48
Prev close
8.50
Mkt cap
27.62M
Vol
5.05K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
8.48
High
8.50
Forward P/E
-0.92
Beta
29.84
Short ratio
4.03
Inst. own
0.59%
Dividend
0.00
Ex-div date
Earnings
Nov 8, 2023
50-d avg
6.68
200-d avg
5.28
1y target
7.53

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for LMNL has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 7.53

Recommendation trend

  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LMNL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.00-5.030.0%00.0%0
Next quarter0.000.00 – 0.00-7.920.0%00.0%0
Current year-8.37-8.37 – -8.370.000.0%00.0%1
Next year-9.11-9.11 – -9.11-8.37-8.8%00.0%1

Upgrades and downgrades

The latest rating changes

LMNL analyst upgrades and downgrades
DateFirmActionFromTo
Jun 24, 2021HC Wainwright & Co.DowngradeBuyNeutral
Jun 2, 2021Piper SandlerDowngradeOverweightNeutral
Feb 18, 2021HC Wainwright & Co.Initiated—Buy
Dec 21, 2020Piper SandlerInitiated—Overweight